Market Research Logo

Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Peptide Therapeutics Market 2018 Forecast to 2023

Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Peptide Therapeutics Market 2018 Forecast to 2023

Peptides are short chains of amino acid monomers linked by peptide (amide) bonds, the covalent chemical bonds formed when the carboxyl group of one amino acid reacts with the amino group of another. Peptides are distinguished from proteins on the basis of size, and as a benchmark can be understood to contain approximately 50 amino acids or less.

Scope of the Report:
This report focuses on the Peptide Therapeutics in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Sanofi
Teva
Novo Nordisk
Takeda
Eli Lilly
AstraZeneca
Novartis
Shire
AbbVie
Ipsen
Allergan
Ferring
Merck
The Medicines
Roche
J & J

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Injection
Oral
Other

Market Segment by Applications, can be divided into
Cancer
Metabolic Disorders
Central Nervous System
Other

There are 15 Chapters to deeply display the global Peptide Therapeutics market.

Chapter 1, to describe Peptide Therapeutics Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Peptide Therapeutics, with sales, revenue, and price of Peptide Therapeutics, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Peptide Therapeutics, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Peptide Therapeutics market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Peptide Therapeutics sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source


1 Market Overview
1.1 Peptide Therapeutics Introduction
1.2 Market Analysis by Type
1.2.1 Injection
1.2.2 Oral
1.2.3 Other
1.3 Market Analysis by Applications
1.3.1 Cancer
1.3.2 Metabolic Disorders
1.3.3 Central Nervous System
1.3.4 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Sanofi
2.1.1 Business Overview
2.1.2 Peptide Therapeutics Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Sanofi Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Teva
2.2.1 Business Overview
2.2.2 Peptide Therapeutics Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Teva Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Novo Nordisk
2.3.1 Business Overview
2.3.2 Peptide Therapeutics Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Novo Nordisk Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Takeda
2.4.1 Business Overview
2.4.2 Peptide Therapeutics Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Takeda Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Eli Lilly
2.5.1 Business Overview
2.5.2 Peptide Therapeutics Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 Eli Lilly Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 AstraZeneca
2.6.1 Business Overview
2.6.2 Peptide Therapeutics Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 AstraZeneca Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Novartis
2.7.1 Business Overview
2.7.2 Peptide Therapeutics Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 Novartis Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Shire
2.8.1 Business Overview
2.8.2 Peptide Therapeutics Type and Applications
2.8.2.1 Type 1
2.8.2.2 Type 2
2.8.3 Shire Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 AbbVie
2.9.1 Business Overview
2.9.2 Peptide Therapeutics Type and Applications
2.9.2.1 Type 1
2.9.2.2 Type 2
2.9.3 AbbVie Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Ipsen
2.10.1 Business Overview
2.10.2 Peptide Therapeutics Type and Applications
2.10.2.1 Type 1
2.10.2.2 Type 2
2.10.3 Ipsen Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Allergan
2.11.1 Business Overview
2.11.2 Peptide Therapeutics Type and Applications
2.11.2.1 Type 1
2.11.2.2 Type 2
2.11.3 Allergan Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Ferring
2.12.1 Business Overview
2.12.2 Peptide Therapeutics Type and Applications
2.12.2.1 Type 1
2.12.2.2 Type 2
2.12.3 Ferring Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Merck
2.13.1 Business Overview
2.13.2 Peptide Therapeutics Type and Applications
2.13.2.1 Type 1
2.13.2.2 Type 2
2.13.3 Merck Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 The Medicines
2.14.1 Business Overview
2.14.2 Peptide Therapeutics Type and Applications
2.14.2.1 Type 1
2.14.2.2 Type 2
2.14.3 The Medicines Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Roche
2.15.1 Business Overview
2.15.2 Peptide Therapeutics Type and Applications
2.15.2.1 Type 1
2.15.2.2 Type 2
2.15.3 Roche Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 J & J
2.16.1 Business Overview
2.16.2 Peptide Therapeutics Type and Applications
2.16.2.1 Type 1
2.16.2.2 Type 2
2.16.3 J & J Peptide Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Peptide Therapeutics Market Competition, by Manufacturer
3.1 Global Peptide Therapeutics Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Peptide Therapeutics Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Peptide Therapeutics Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Peptide Therapeutics Manufacturer Market Share in 2017
3.4.2 Top 5 Peptide Therapeutics Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 Global Peptide Therapeutics Market Analysis by Regions
4.1 Global Peptide Therapeutics Sales, Revenue and Market Share by Regions
4.1.1 Global Peptide Therapeutics Sales by Regions (2013-2018)
4.1.2 Global Peptide Therapeutics Revenue by Regions (2013-2018)
4.2 North America Peptide Therapeutics Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Peptide Therapeutics Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Peptide Therapeutics Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Peptide Therapeutics Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Peptide Therapeutics Sales, Revenue and Growth Rate (2013-2018)
5 North America Peptide Therapeutics by Countries, Type, Application and Manufacturers
5.1 North America Peptide Therapeutics Sales, Revenue and Market Share by Countries
5.1.1 North America Peptide Therapeutics Sales by Countries (2013-2018)
5.1.2 North America Peptide Therapeutics Revenue by Countries (2013-2018)
5.1.3 United States Peptide Therapeutics Sales and Growth Rate (2013-2018)
5.1.4 Canada Peptide Therapeutics Sales and Growth Rate (2013-2018)
5.1.5 Mexico Peptide Therapeutics Sales and Growth Rate (2013-2018)
5.2 North America Peptide Therapeutics Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Peptide Therapeutics Sales by Manufacturers (2016-2017)
5.2.2 North America Peptide Therapeutics Revenue by Manufacturers (2016-2017)
5.3 North America Peptide Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Peptide Therapeutics Sales and Sales Share by Type (2013-2018)
5.3.2 North America Peptide Therapeutics Revenue and Revenue Share by Type (2013-2018)
5.4 North America Peptide Therapeutics Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Peptide Therapeutics Sales and Sales Share by Application (2013-2018)
5.4.2 North America Peptide Therapeutics Revenue and Revenue Share by Application (2013-2018)
6 Europe Peptide Therapeutics by Countries, Type, Application and Manufacturers
6.1 Europe Peptide Therapeutics Sales, Revenue and Market Share by Countries
6.1.1 Europe Peptide Therapeutics Sales by Countries (2013-2018)
6.1.2 Europe Peptide Therapeutics Revenue by Countries (2013-2018)
6.1.3 Germany Peptide Therapeutics Sales and Growth Rate (2013-2018)
6.1.4 UK Peptide Therapeutics Sales and Growth Rate (2013-2018)
6.1.5 France Peptide Therapeutics Sales and Growth Rate (2013-2018)
6.1.6 Russia Peptide Therapeutics Sales and Growth Rate (2013-2018)
6.1.7 Italy Peptide Therapeutics Sales and Growth Rate (2013-2018)
6.2 Europe Peptide Therapeutics Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Peptide Therapeutics Sales by Manufacturers (2016-2017)
6.2.2 Europe Peptide Therapeutics Revenue by Manufacturers (2016-2017)
6.3 Europe Peptide Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Peptide Therapeutics Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Peptide Therapeutics Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Peptide Therapeutics Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Peptide Therapeutics Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Peptide Therapeutics Revenue and Revenue Share by Application (2013-2018)
7 Asia-Pacific Peptide Therapeutics by Countries, Type, Application and Manufacturers
7.1 Asia-Pacific Peptide Therapeutics Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Peptide Therapeutics Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Peptide Therapeutics Revenue by Countries (2013-2018)
7.1.3 China Peptide Therapeutics Sales and Growth Rate (2013-2018)
7.1.4 Japan Peptide Therapeutics Sales and Growth Rate (2013-2018)
7.1.5 Korea Peptide Therapeutics Sales and Growth Rate (2013-2018)
7.1.6 India Peptide Therapeutics Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Peptide Therapeutics Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Peptide Therapeutics Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Peptide Therapeutics Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Peptide Therapeutics Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Peptide Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Peptide Therapeutics Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Peptide Therapeutics Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Peptide Therapeutics Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Peptide Therapeutics Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Peptide Therapeutics Revenue and Revenue Share by Application (2013-2018)
8 South America Peptide Therapeutics by Countries, Type, Application and Manufacturers
8.1 South America Peptide Therapeutics Sales, Revenue and Market Share by Countries
8.1.1 South America Peptide Therapeutics Sales by Countries (2013-2018)
8.1.2 South America Peptide Therapeutics Revenue by Countries (2013-2018)
8.1.3 Brazil Peptide Therapeutics Sales and Growth Rate (2013-2018)
8.1.4 Argentina Peptide Therapeutics Sales and Growth Rate (2013-2018)
8.1.5 Colombia Peptide Therapeutics Sales and Growth Rate (2013-2018)
8.2 South America Peptide Therapeutics Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Peptide Therapeutics Sales by Manufacturers (2016-2017)
8.2.2 South America Peptide Therapeutics Revenue by Manufacturers (2016-2017)
8.3 South America Peptide Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Peptide Therapeutics Sales and Sales Share by Type (2013-2018)
8.3.2 South America Peptide Therapeutics Revenue and Revenue Share by Type (2013-2018)
8.4 South America Peptide Therapeutics Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Peptide Therapeutics Sales and Sales Share by Application (2013-2018)
8.4.2 South America Peptide Therapeutics Revenue and Revenue Share by Application (2013-2018)
9 Middle East and Africa Peptide Therapeutics by Countries, Type, Application and Manufacturers
9.1 Middle East and Africa Peptide Therapeutics Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Peptide Therapeutics Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Peptide Therapeutics Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Peptide Therapeutics Sales and Growth Rate (2013-2018)
9.1.4 UAE Peptide Therapeutics Sales and Growth Rate (2013-2018)
9.1.5 Egypt Peptide Therapeutics Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Peptide Therapeutics Sales and Growth Rate (2013-2018)
9.1.7 South Africa Peptide Therapeutics Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Peptide Therapeutics Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Peptide Therapeutics Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Peptide Therapeutics Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Peptide Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Peptide Therapeutics Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Peptide Therapeutics Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Peptide Therapeutics Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Peptide Therapeutics Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Peptide Therapeutics Revenue and Revenue Share by Application (2013-2018)
10 Global Peptide Therapeutics Market Segment by Type
10.1 Global Peptide Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Peptide Therapeutics Sales and Market Share by Type (2013-2018)
10.1.2 Global Peptide Therapeutics Revenue and Market Share by Type (2013-2018)
10.2 Injection Sales Growth and Price
10.2.1 Global Injection Sales Growth (2013-2018)
10.2.2 Global Injection Price (2013-2018)
10.3 Oral Sales Growth and Price
10.3.1 Global Oral Sales Growth (2013-2018)
10.3.2 Global Oral Price (2013-2018)
10.4 Other Sales Growth and Price
10.4.1 Global Other Sales Growth (2013-2018)
10.4.2 Global Other Price (2013-2018)
11 Global Peptide Therapeutics Market Segment by Application
11.1 Global Peptide Therapeutics Sales Market Share by Application (2013-2018)
11.2 Cancer Sales Growth (2013-2018)
11.3 Metabolic Disorders Sales Growth (2013-2018)
11.4 Central Nervous System Sales Growth (2013-2018)
11.5 Other Sales Growth (2013-2018)
12 Peptide Therapeutics Market Forecast (2018-2023)
12.1 Global Peptide Therapeutics Sales, Revenue and Growth Rate (2018-2023)
12.2 Peptide Therapeutics Market Forecast by Regions (2018-2023)
12.2.1 North America Peptide Therapeutics Market Forecast (2018-2023)
12.2.2 Europe Peptide Therapeutics Market Forecast (2018-2023)
12.2.3 Asia-Pacific Peptide Therapeutics Market Forecast (2018-2023)
12.2.4 South America Peptide Therapeutics Market Forecast (2018-2023)
12.2.5 Middle East and Africa Peptide Therapeutics Market Forecast (2018-2023)
12.3 Peptide Therapeutics Market Forecast by Type (2018-2023)
12.3.1 Global Peptide Therapeutics Sales Forecast by Type (2018-2023)
12.3.2 Global Peptide Therapeutics Market Share Forecast by Type (2018-2023)
12.4 Peptide Therapeutics Market Forecast by Application (2018-2023)
12.4.1 Global Peptide Therapeutics Sales Forecast by Application (2018-2023)
12.4.2 Global Peptide Therapeutics Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report